We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




Optimized Pooled Testing Approach Could Transform Public Health Screening for Infectious Diseases

By LabMedica International staff writers
Posted on 13 Dec 2024

Traditional individual testing methods can be resource-intensive, particularly when it comes to large-scale screenings. More...

Pooled testing, on the other hand, enables the testing of multiple specimens together, which reduces both cost and time. This approach has been particularly useful in situations where disease prevalence is low, such as during early screenings or when monitoring for diseases like HIV and chlamydia. In an effort to accelerate and make large-scale disease testing more affordable, researchers have now created an optimized method for pooled testing, which has the potential to revolutionize public health screening for infectious diseases.

A study conducted by researchers at the University of Louisiana at Lafayette (Lafayette, LA, USA) examined the benefits of using pooled testing for detecting infectious diseases, particularly in cases of low prevalence. The team developed a framework to determine the most effective pool size for different infectious diseases, balancing both cost and testing efficiency. Their research utilized data on diseases like HIV, gonorrhea, chlamydia, and SARS-CoV-2.

The researchers found that by strategically pooling specimens, testing costs could be significantly reduced without sacrificing accuracy—an important discovery as health systems face increasing demand for screening across various diseases, including HIV, gonorrhea, and COVID-19. Their findings, published in the Journal of Agricultural, Biological, and Environmental Statistics, revealed that by adjusting pool sizes according to specific infection prevalence rates, public health agencies could realize considerable cost savings while still ensuring accurate prevalence estimates. The software tools developed in this study are now available for download, providing valuable resources for public health officials and researchers worldwide.

“Our findings suggest that careful design and optimization of pooled testing can yield substantial benefits for disease surveillance efforts, particularly in resource-limited settings,” said Dr. Md S. Warasi, Assistant Professor of Mathematics and Statistics at Radford University. “The study provides a new software package and a user-friendly software application to aid health departments and researchers in implementing these optimized testing protocols.”

“The ability to efficiently detect and monitor infectious diseases is crucial for timely interventions. By refining how pooled testing is conducted, we hope to empower health departments worldwide to improve their screening processes and respond faster to potential outbreaks,” added Dr. Kumer P. Das, Assistant Vice President for Research and Innovation at theUniversity of Louisiana at Lafayette.

 


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Hemoglobin Stool Test
CerTest FOB 50 + 200 One Step Combo Card Test
New
Whole Blood Control
Lyphochek Whole Blood Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.